Page last updated: 2024-12-05

trifluoroiodomethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID16843
MeSH IDM0274205

Synonyms (36)

Synonym
methane, trifluoroiodo-
iodotrifluoromethane
monoiodotrifluoromethane
freon 13t1
trifluoroiodomethane
ccris 7782
perfluoromethyl iodide
einecs 219-014-5
trifluoromethyl iodide
trifluoroiodomethane, 99%
trifluoro(iodo)methane
AKOS005063459
unii-42a379kb0u
42a379kb0u ,
2314-97-8
tris(fluoranyl)-iodanyl-methane
A816593
FT-0627274
trifluoroiodomethane [mi]
T3957
trifluoromethyliodide
trifluoro-methyl iodide
cf3i
DTXSID2062325
T3958
cif3
trifluoriodomethane
mfcd00001060
trifluoromethyl iodide 99%
Q7841502
FS-3814
AMY6767
trifluoro-iodo-methane
lodotrifluoromethane
trifluoroiodomethane (ca. 10% in tetrahydrofuran, ca. 0.5mol/l)
trifluoroiodomethane (ca. 10% in dimethyl sulfoxide, ca. 0.6mol/l)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The acute toxic endpoint of concern for these agents is cardiac sensitization."( Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling.
Brock, WJ; Cisneros, M; Jepson, GW; Rubenstein, R; Vinegar, A, 2000
)
0.31

Pharmacokinetics

ExcerptReferenceRelevance
" Linkage was made using a physiologically based pharmacokinetic (PBPK) model."( Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling.
Brock, WJ; Cisneros, M; Jepson, GW; Rubenstein, R; Vinegar, A, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's4 (25.00)29.6817
2010's8 (50.00)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.01 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]